[go: up one dir, main page]

TR200000957T2 - Hiperglisemi tedavisinde tiazolidinedion kullanımı - Google Patents

Hiperglisemi tedavisinde tiazolidinedion kullanımı

Info

Publication number
TR200000957T2
TR200000957T2 TR2000/00957T TR200000957T TR200000957T2 TR 200000957 T2 TR200000957 T2 TR 200000957T2 TR 2000/00957 T TR2000/00957 T TR 2000/00957T TR 200000957 T TR200000957 T TR 200000957T TR 200000957 T2 TR200000957 T2 TR 200000957T2
Authority
TR
Turkey
Prior art keywords
hyperglycemia
thiazolidinedione
treatment
mammal
toxic
Prior art date
Application number
TR2000/00957T
Other languages
English (en)
Inventor
Edwin Buckingham Robin
Alistair Smith Stephen
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR200000957T2 publication Critical patent/TR200000957T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Plazma glükoz seviyelerinin 126mg/dI ila 140 mg/dI, arasinda oldugu hiperglisemi için tedavisi için, ihtiyaci olan bir memeliye etkili bir toksik olmayan ve farmasötik olarak kabul edilebilir miktarlarda bir ensülin sensitizörü uygulanmasini içeren bir yöntem.
TR2000/00957T 1997-10-13 1998-10-12 Hiperglisemi tedavisinde tiazolidinedion kullanımı TR200000957T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9721692.3A GB9721692D0 (en) 1997-10-13 1997-10-13 Novel treatment

Publications (1)

Publication Number Publication Date
TR200000957T2 true TR200000957T2 (tr) 2000-08-21

Family

ID=10820481

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00957T TR200000957T2 (tr) 1997-10-13 1998-10-12 Hiperglisemi tedavisinde tiazolidinedion kullanımı

Country Status (24)

Country Link
EP (1) EP1023057A1 (tr)
JP (1) JP2001519383A (tr)
KR (1) KR20010024482A (tr)
CN (1) CN1281358A (tr)
AP (1) AP1223A (tr)
AU (1) AU9547198A (tr)
BG (1) BG104405A (tr)
BR (1) BR9815220A (tr)
CA (1) CA2305289A1 (tr)
CZ (1) CZ20001298A3 (tr)
EA (1) EA200000418A1 (tr)
GB (1) GB9721692D0 (tr)
HR (1) HRP20000256A2 (tr)
HU (1) HUP0003673A3 (tr)
ID (1) ID24439A (tr)
IL (1) IL135515A0 (tr)
NO (1) NO20001897L (tr)
OA (1) OA11519A (tr)
PL (1) PL339804A1 (tr)
SK (1) SK5322000A3 (tr)
TR (1) TR200000957T2 (tr)
UA (1) UA66809C2 (tr)
WO (1) WO1999018944A1 (tr)
YU (1) YU28700A (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
AP2001002036A0 (en) * 1998-07-21 2001-03-31 Smithkline Beecham Plc Use of glucose uptake enhancer for reducing apoptosis.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306228B1 (en) * 1987-09-04 1999-11-17 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
YU28700A (sh) 2003-10-31
AP2000001788A0 (en) 2000-06-30
CA2305289A1 (en) 1999-04-22
OA11519A (en) 2004-02-09
EP1023057A1 (en) 2000-08-02
WO1999018944A1 (en) 1999-04-22
AU9547198A (en) 1999-05-03
PL339804A1 (en) 2001-01-02
JP2001519383A (ja) 2001-10-23
BR9815220A (pt) 2000-11-14
CN1281358A (zh) 2001-01-24
NO20001897D0 (no) 2000-04-12
CZ20001298A3 (cs) 2001-08-15
NO20001897L (no) 2000-06-09
EA200000418A1 (ru) 2000-10-30
HRP20000256A2 (en) 2000-12-31
HUP0003673A2 (hu) 2001-10-28
IL135515A0 (en) 2001-05-20
AP1223A (en) 2003-11-13
HUP0003673A3 (en) 2001-12-28
GB9721692D0 (en) 1997-12-10
BG104405A (en) 2000-12-29
UA66809C2 (uk) 2004-06-15
KR20010024482A (ko) 2001-03-26
SK5322000A3 (en) 2000-09-12
ID24439A (id) 2000-07-20

Similar Documents

Publication Publication Date Title
CA2071629A1 (en) Use of insulin sensitizing agents to treat hypertension
AP2001002291A0 (en) Novel method of treatment.
TR200101174T2 (tr) Migren tedavisi için 5HT1, reseptör agonistleri ve metoklopramid.
SG127714A1 (en) Method of treating metabolic disorders, especiallydiabetes, or a disease or condition associated wi th diabetes
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
MXPA03003870A (es) Terapia de combinacion que comprende agentes antidiabeticos y anticonvulsionantes.
BR0308904A (pt) Método de tratamento de gastroparesia, e, uso de um composto de glp-1
CY1105254T1 (el) Θepαπεια του διαβητη με θειαζολιδινδιονη, εκκριταγωγο ινσουλινης και διγουανιδιο
NO20083276L (no) Behandling av diabetes med tiazolidindion og sulfonylurea
CY1107745T1 (el) Αγωγη του διαβητη με θειαζολιδινοδιονη και σουλφονυλουρια
TR200000957T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı
AP9901720A0 (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitors.
BR9810292A (pt) Tratamento de diabete com tiazolidinadiona, secretagogo de insulina e inibidor de alfa-glicosidase
TR200101336T2 (tr) Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar
NO20005223L (no) Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen
TR200000958T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı.
TR200202033T2 (tr) Epilepsi Tedavisi İçin Terkipler ve Yöntemler
TR199801133T2 (tr) Tip II diyabetin tedavisi veya önlenmesi için nitrik oksit (NO) sentaz inhibitörü
WO2001047509A3 (en) Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions
ECSP982541A (es) Nuevo metodo de tratamiento ii
MX9701532A (es) Procedimiento para aumentar los niveles de testosterona.
MX9701529A (es) Uso de (e)-1-[4'-(2-alquilaminoetoxi)fenil]-1-(3'-hidroxifenil)-2-f enilbut-1-enos para inhibir trastornos patologicos.